Su1616 GLP-1 USAGE REDUCES THE RISK OF DEVELOPING HCC IN PATIENTS WITH CO-EXISTING METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS AND TYPE 2 DIABETES: A GLOBAL MULTICENTER PROPENSITY-MATCHED STUDY

Abstract

Peer reviewed

Abdullah Sohail, Aysha Aslam, Muhammad M. Bhinder and Kyle Brown

Gastroenterology (New York, N.Y. 1943), Vol.166(5 Supplement), pp.S-1666-S-1666

05/18/2024

DOI: 10.1016/S0016-5085(24)04285-9

View Online

Title: Subtitle: Su1616 GLP-1 USAGE REDUCES THE RISK OF DEVELOPING HCC IN PATIENTS WITH CO-EXISTING METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS AND TYPE 2 DIABETES: A GLOBAL MULTICENTER PROPENSITY-MATCHED STUDY
Creators: Abdullah Sohail
Aysha Aslam
Muhammad M. Bhinder
Kyle Brown
Resource Type: Abstract
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.166(5 Supplement), pp.S-1666-S-1666
DOI: 10.1016/S0016-5085(24)04285-9
ISSN: 0016-5085
eISSN: 1528-0012
Language: English
Date published: 05/18/2024
Academic Unit: Internal Medicine
Record Identifier: 9984695806702771

2 Record Views